Danaher Corporation balance sheet
At the end of fiscal 2025, Danaher Corporation had total assets of $83.46bn and shareholders' equity of $52.53bn. It held $4.62bn in cash against $18.42bn of debt: net debt of $13.80bn.
Balance sheet
| Fiscal year | 2009Dec 2009 | 2010Dec 2010 | 2011Dec 2011 | 2012Dec 2012 | 2013Dec 2013 | 2014Dec 2014 | 2015Dec 2015 | 2016Dec 2016 | 2017Dec 2017 | 2018Dec 2018 | 2019Dec 2019 | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMSept 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 1.7 | 1.6 | 0.5 | 1.7 | 3.1 | 3.0 | 0.8 | 1.0 | 0.6 | 0.8 | 19.9 | 6.0 | 2.6 | 6.0 | 5.9 | 2.1 | 4.6 | 5.7 |
| Receivables | 1.9 | 2.1 | 3.0 | 3.3 | 3.5 | 3.4 | 3.0 | 3.2 | 3.5 | 3.0 | 3.2 | 4.0 | 4.6 | 4.1 | 3.9 | 3.5 | 3.9 | 4.1 |
| Inventory | 1.0 | 1.2 | 1.8 | 1.8 | 1.8 | 1.8 | 1.6 | 1.7 | 1.8 | 1.6 | 1.6 | 2.3 | 2.8 | 2.8 | 2.6 | 2.3 | 2.5 | 3.1 |
| Total current assets | 5.2 | 6.1 | 6.3 | 7.6 | 9.1 | 9.4 | 7.8 | 6.7 | 6.9 | 7.1 | 25.6 | 13.8 | 11.6 | 15.9 | 13.9 | 9.5 | 12.8 | 14.8 |
| Goodwill | 9.5 | 10.4 | 14.5 | 15.5 | 14.7 | 11.6 | 21.0 | 23.8 | 21.8 | 22.6 | 22.7 | 35.4 | 38.7 | 37.3 | 41.6 | 40.5 | 43.2 | 47.3 |
| Total assets | 19.6 | 22.2 | 29.9 | 32.9 | 34.7 | 37.0 | 48.2 | 45.3 | 46.6 | 47.8 | 62.1 | 76.2 | 83.2 | 84.4 | 84.5 | 77.5 | 83.5 | 93.3 |
| Deferred revenue (current) | — | — | — | — | 0.7 | 0.6 | 0.5 | 0.5 | 0.7 | 0.7 | 0.7 | 1.2 | 1.6 | 1.5 | 1.5 | 1.3 | 1.4 | — |
| Total current liabilities | 2.8 | 3.3 | 4.2 | 4.2 | 4.5 | 5.4 | 6.2 | 6.9 | 4.8 | 4.8 | 4.9 | 7.4 | 8.1 | 8.4 | 8.3 | 6.8 | 6.8 | 9.1 |
| Short-term debt | 0.0 | 0.0 | 0.1 | 0.1 | 0.1 | 0.1 | 0.8 | 2.6 | 0.2 | 0.1 | 0.2 | 0.0 | 0.0 | 0.6 | 1.7 | 0.5 | 0.0 | 2.1 |
| Long-term debt | 2.9 | 2.8 | 5.2 | 5.3 | 3.4 | 3.4 | 12.0 | 9.7 | 10.3 | 9.7 | 21.5 | 21.2 | 22.2 | 19.1 | 16.7 | 15.5 | 18.4 | 24.4 |
| Total debt | 3.1 | 3.0 | 6.3 | 6.6 | 3.9 | 4.2 | 12.9 | 12.3 | 10.5 | 9.7 | 21.7 | 21.2 | 22.2 | 19.7 | 18.4 | 16.0 | 18.4 | 26.5 |
| Total liabilities | 8.0 | 8.4 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Shareholders' equity | 11.6 | 13.7 | 16.9 | 19.0 | 22.4 | 23.4 | 23.7 | 23.0 | 26.4 | 28.2 | 30.3 | 39.8 | 45.2 | 50.1 | 53.5 | 49.5 | 52.5 | 53.6 |
| Net debt (negative = net cash) | 1.4 | 1.4 | 5.7 | 4.9 | 0.8 | 1.2 | 12.1 | 11.3 | 9.9 | 9.0 | 1.8 | 15.2 | 19.6 | 13.7 | 12.5 | 13.9 | 13.8 | 20.8 |
| Shares outstanding | 645m | 656m | 688m | 688m | 698m | 704m | 687m | 692m | 697m | 702m | 696m | 711m | 715m | 728m | 739m | 719m | 707m | 703m |
| Quarter | 2024 Q4Dec 2024 | 2025 Q1Mar 2025 | 2025 Q2Jun 2025 | 2025 Q3Sept 2025 | 2025 Q4Dec 2025 | 2026 Q1Mar 2026 | 2026 Q2Jun 2026 | 2026 Q3Sept 2026 |
|---|---|---|---|---|---|---|---|---|
| Receivables | 3.5 | 3.5 | 3.6 | 3.8 | 3.9 | 3.8 | 4.0 | 4.1 |
| Inventory | 2.3 | 2.5 | 2.7 | 2.7 | 2.5 | 2.6 | 3.3 | 3.1 |
| Total current assets | 9.5 | 9.5 | 11.0 | 9.6 | 12.8 | 13.9 | 13.4 | 14.8 |
| Goodwill | 40.5 | 41.7 | 43.0 | 42.9 | 43.2 | 42.8 | 47.4 | 47.3 |
| Total assets | 77.5 | 79.1 | 81.6 | 79.9 | 83.5 | 83.5 | 92.4 | 93.3 |
| Deferred revenue (current) | 1.3 | — | — | — | 1.4 | — | — | — |
| Total current liabilities | 6.8 | 6.6 | 6.8 | 6.3 | 6.8 | 7.5 | 8.1 | 9.1 |
| Short-term debt | 0.5 | 0.5 | 0.5 | 0.0 | 0.0 | 0.9 | 1.4 | 2.1 |
| Long-term debt | 15.5 | 16.0 | 16.9 | 16.8 | 18.4 | 17.6 | 25.1 | 24.4 |
| Total debt | 16.0 | 16.5 | 17.4 | 16.9 | 18.4 | 18.5 | 26.6 | 26.5 |
| Shareholders' equity | 49.5 | 50.8 | 52.3 | 51.1 | 52.5 | 52.9 | 52.6 | 53.6 |
| Shares outstanding | 719m | 716m | 716m | 706m | 707m | 708m | 703m | 703m |
Compare with peers
- IQVIA balance sheet
- Thermo Fisher Scientific balance sheet
- Icon PLC balance sheet
- Agilent Technologies balance sheet
- Avantor, Inc. balance sheet
Head to head: DHR vs IQVDHR vs TMODHR vs ICLR
More: Life Sciences Tools & Services stocks compared, Health Care sector, rankings of US companies